THERAPEUTIC BINDING MOLECULES
The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | REES, David Gareth NYS, Josquin Arnaud HUNTINGTON, Catherine Eugenie Chaillan ROBINSON, Matthew THOM, Albert George CARIUK, Peter RILEY, Aidan SCHOFIELD, Darren Jonathan IRVING, Lorraine |
| description | The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.
L'invention concerne des molécules de liaison, telles que des anticorps, qui se lient au récepteur CCR9 de chimiokine. Plus particulièrement, l'invention concerne le traitement de maladies ou de pathologies à médiation par CCR9 telles qu'une maladie intestinale inflammatoire (IBD), et des méthodes de détection de CCR9, qui font appel aux molécules de liaison de l'invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022195028A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022195028A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022195028A23</originalsourceid><addsrcrecordid>eNrjZJAN8XANcgxwDQ3xdFZw8vRz8fRzV_D193F1DvVxDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGlqYGRhaORsbEqQIAIMUiFg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THERAPEUTIC BINDING MOLECULES</title><source>esp@cenet</source><creator>REES, David Gareth ; NYS, Josquin Arnaud ; HUNTINGTON, Catherine Eugenie Chaillan ; ROBINSON, Matthew ; THOM, Albert George ; CARIUK, Peter ; RILEY, Aidan ; SCHOFIELD, Darren Jonathan ; IRVING, Lorraine</creator><creatorcontrib>REES, David Gareth ; NYS, Josquin Arnaud ; HUNTINGTON, Catherine Eugenie Chaillan ; ROBINSON, Matthew ; THOM, Albert George ; CARIUK, Peter ; RILEY, Aidan ; SCHOFIELD, Darren Jonathan ; IRVING, Lorraine</creatorcontrib><description>The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.
L'invention concerne des molécules de liaison, telles que des anticorps, qui se lient au récepteur CCR9 de chimiokine. Plus particulièrement, l'invention concerne le traitement de maladies ou de pathologies à médiation par CCR9 telles qu'une maladie intestinale inflammatoire (IBD), et des méthodes de détection de CCR9, qui font appel aux molécules de liaison de l'invention.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220922&DB=EPODOC&CC=WO&NR=2022195028A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25565,76548</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220922&DB=EPODOC&CC=WO&NR=2022195028A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REES, David Gareth</creatorcontrib><creatorcontrib>NYS, Josquin Arnaud</creatorcontrib><creatorcontrib>HUNTINGTON, Catherine Eugenie Chaillan</creatorcontrib><creatorcontrib>ROBINSON, Matthew</creatorcontrib><creatorcontrib>THOM, Albert George</creatorcontrib><creatorcontrib>CARIUK, Peter</creatorcontrib><creatorcontrib>RILEY, Aidan</creatorcontrib><creatorcontrib>SCHOFIELD, Darren Jonathan</creatorcontrib><creatorcontrib>IRVING, Lorraine</creatorcontrib><title>THERAPEUTIC BINDING MOLECULES</title><description>The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.
L'invention concerne des molécules de liaison, telles que des anticorps, qui se lient au récepteur CCR9 de chimiokine. Plus particulièrement, l'invention concerne le traitement de maladies ou de pathologies à médiation par CCR9 telles qu'une maladie intestinale inflammatoire (IBD), et des méthodes de détection de CCR9, qui font appel aux molécules de liaison de l'invention.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAN8XANcgxwDQ3xdFZw8vRz8fRzV_D193F1DvVxDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGlqYGRhaORsbEqQIAIMUiFg</recordid><startdate>20220922</startdate><enddate>20220922</enddate><creator>REES, David Gareth</creator><creator>NYS, Josquin Arnaud</creator><creator>HUNTINGTON, Catherine Eugenie Chaillan</creator><creator>ROBINSON, Matthew</creator><creator>THOM, Albert George</creator><creator>CARIUK, Peter</creator><creator>RILEY, Aidan</creator><creator>SCHOFIELD, Darren Jonathan</creator><creator>IRVING, Lorraine</creator><scope>EVB</scope></search><sort><creationdate>20220922</creationdate><title>THERAPEUTIC BINDING MOLECULES</title><author>REES, David Gareth ; NYS, Josquin Arnaud ; HUNTINGTON, Catherine Eugenie Chaillan ; ROBINSON, Matthew ; THOM, Albert George ; CARIUK, Peter ; RILEY, Aidan ; SCHOFIELD, Darren Jonathan ; IRVING, Lorraine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022195028A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>REES, David Gareth</creatorcontrib><creatorcontrib>NYS, Josquin Arnaud</creatorcontrib><creatorcontrib>HUNTINGTON, Catherine Eugenie Chaillan</creatorcontrib><creatorcontrib>ROBINSON, Matthew</creatorcontrib><creatorcontrib>THOM, Albert George</creatorcontrib><creatorcontrib>CARIUK, Peter</creatorcontrib><creatorcontrib>RILEY, Aidan</creatorcontrib><creatorcontrib>SCHOFIELD, Darren Jonathan</creatorcontrib><creatorcontrib>IRVING, Lorraine</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REES, David Gareth</au><au>NYS, Josquin Arnaud</au><au>HUNTINGTON, Catherine Eugenie Chaillan</au><au>ROBINSON, Matthew</au><au>THOM, Albert George</au><au>CARIUK, Peter</au><au>RILEY, Aidan</au><au>SCHOFIELD, Darren Jonathan</au><au>IRVING, Lorraine</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THERAPEUTIC BINDING MOLECULES</title><date>2022-09-22</date><risdate>2022</risdate><abstract>The invention relates to binding molecules, such as antibodies, that bind to the chemokine receptor CCR9. More particularly, the invention relates to the treatment of CCR9-mediated diseases or conditions such as inflammatory bowel disease (IBD), and methods for the detection of CCR9, which make use of the binding molecules of the invention.
L'invention concerne des molécules de liaison, telles que des anticorps, qui se lient au récepteur CCR9 de chimiokine. Plus particulièrement, l'invention concerne le traitement de maladies ou de pathologies à médiation par CCR9 telles qu'une maladie intestinale inflammatoire (IBD), et des méthodes de détection de CCR9, qui font appel aux molécules de liaison de l'invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022195028A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | THERAPEUTIC BINDING MOLECULES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T14%3A19%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REES,%20David%20Gareth&rft.date=2022-09-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022195028A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |